Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 27 Non-metastatic Castration-resistant Prostate Cancer 2 Neoplasm Metastasis 2 Urogenital Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 Non-metastatic Prostate Cancer 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoplasms by Site 1 Neoplasms 1 Metastatic Castration-Resistant Prostate Cancer 1 Low Risk Prostate Cancer 1 Genital Neoplasms, Male 1 Genital Diseases, Male 1 Castration Levels of Testosterone 1 Advanced Prostate Carcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Low Risk Prostate Cancer × apalutamide × Clear all

NCT03088124 2026-03-20

PC-ARN

Institut Paoli-Calmettes

Phase 2 Completed

Low Risk Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡